Stoke Therapeutics (STOK) Institutional Ownership $9.50 +0.02 (+0.21%) Closing price 05/22/2025 04:00 PM EasternExtended Trading$9.55 +0.05 (+0.53%) As of 05/22/2025 05:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Stoke Therapeutics (NASDAQ:STOK)Number ofInstitutional Buyers(last 12 months)75TotalInstitutional Inflows(last 12 months)$233.43MNumber ofInstitutional Sellers(last 12 months)34TotalInstitutional Outflows(last 12 months)$93.50M Get STOK Insider Trade Alerts Want to know when executives and insiders are buying or selling Stoke Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data STOK Institutional Buying and Selling by Quarter Stoke Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/23/2025 Siren L.L.C.2,247,347$14.95M0.9%+12.4%4.116% 5/19/2025 Jane Street Group LLC26,978$179K0.0%+125.2%0.049% 5/16/2025 Goldman Sachs Group Inc.1,662,039$11.05M0.0%+21.4%3.044% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.24,167$162K0.0%+5.0%0.044% 5/16/2025 Jacobs Levy Equity Management Inc.357,248$2.38M0.0%N/A0.654% 5/16/2025 Granahan Investment Management LLC660,430$4.39M0.2%+16.3%1.210% 5/16/2025 Checkpoint Capital L.P.730,717$4.86M2.7%+139.3%1.338% 5/16/2025 AQR Capital Management LLC12,847$85K0.0%-45.6%0.024% 5/16/2025 ADAR1 Capital Management LLC30,085$200K0.0%N/A0.055% 5/15/2025 Redmile Group LLC4,485,981$29.83M2.8%-2.3%8.217% Get the Latest News and Ratings for STOK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Stoke Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/15/2025 MPM Bioimpact LLC693,988$4.62M0.8%+1.2%1.271% 5/15/2025 DAFNA Capital Management LLC443,998$2.95M0.8%+159.5%0.813% 5/15/2025 Siren L.L.C.2,247,347$14.95M0.9%+12.4%4.116% 5/15/2025 Trexquant Investment LP86,140$573K0.0%-16.4%0.158% 5/14/2025 Rafferty Asset Management LLC61,706$410K0.0%-8.2%0.113% 5/14/2025 AlphaQuest LLC10,832$72K0.0%N/A0.020% 5/14/2025 Erste Asset Management GmbH396,000$2.67M0.0%N/A0.725% 5/14/2025 Wellington Management Group LLP135,960$904K0.0%+0.9%0.249% 5/13/2025 Fox Run Management L.L.C.13,780$92K0.0%N/A0.025% 5/13/2025 Russell Investments Group Ltd.16,119$107K0.0%N/A0.030% 5/12/2025 Nuveen LLC108,087$719K0.0%N/A0.198% 5/12/2025 Invesco Ltd.26,183$174K0.0%+117.0%0.048% 5/9/2025 Deutsche Bank AG25,566$170K0.0%-92.7%0.047% 5/9/2025 Charles Schwab Investment Management Inc.310,307$2.06M0.0%-9.3%0.568% 5/9/2025 Vanguard Group Inc.2,784,202$18.52M0.0%+1.9%5.100% 5/8/2025 US Bancorp DE11,222$75K0.0%+9,743.9%0.021% 5/8/2025 XTX Topco Ltd40,181$267K0.0%N/A0.074% 5/7/2025 Dauntless Investment Group LLC28,600$190K0.2%N/A0.052% 5/6/2025 Kennondale Capital Management LLC42,100$280K0.3%N/A0.077% 4/30/2025 Alps Advisors Inc.39,890$265K0.0%-6.9%0.073% 4/29/2025 Bank of New York Mellon Corp89,985$598K0.0%-3.4%0.165% 4/15/2025 Net Worth Advisory Group20,741$138K0.0%N/A0.038% 4/15/2025 Assenagon Asset Management S.A.959,603$6.38M0.0%-29.0%1.774% 4/7/2025 GAMMA Investing LLC5,360$36K0.0%+1,842.0%0.010% 3/24/2025 Wellington Management Group LLP134,812$1.49M0.0%-1.6%0.249% 3/18/2025 California State Teachers Retirement System32,068$354K0.0%+16.2%0.061% 2/19/2025 Toronto Dominion Bank3,173,258$35.00M0.1%N/A5.991% 2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC95,505$1.05M0.0%+123.7%0.180% 2/17/2025 Voloridge Investment Management LLC86,888$958K0.0%-29.4%0.164% 2/17/2025 Squarepoint Ops LLC120,242$1.33M0.0%+6.7%0.227% Volatility Is Rising—But These 2 AI Stocks Could Thrive (Ad)2025 is off to a turbulent start—markets are swinging wildly, inflation pressures remain high, and recession fears are creeping back into headlines. But even in uncertain times, innovation doesn’t slow down. In fact, artificial intelligence (AI) is accelerating faster than ever—creating new profit opportunities while the broader market struggles. Our latest research reveals two AI stocks trading under $15 that could thrive even as volatility grows. These under-the-radar companies are positioned to ride the next wave of AI-driven demand—and they’re still flying below most investors’ radar.👉[Click here to access your FREE AI stocks report now.]2/17/2025 Two Sigma Investments LP53,950$595K0.0%-53.8%0.102% 2/17/2025 Tang Capital Management LLC300,000$3.31M0.2%N/A0.566% 2/17/2025 Toronto Dominion Bank3,173,258$35.00M0.1%N/A5.991% 2/17/2025 RTW Investments LP5,123,525$56.51M0.9%+10.1%9.673% 2/17/2025 Rafferty Asset Management LLC67,227$742K0.0%-18.8%0.127% 2/17/2025 Redmile Group LLC4,593,629$50.67M3.5%-2.5%8.672% 2/17/2025 ProShare Advisors LLC12,626$139K0.0%N/A0.024% 2/17/2025 MPM Bioimpact LLC685,826$7.57M1.1%+43.0%1.295% 2/17/2025 Millennium Management LLC76,829$847K0.0%+417.9%0.145% 2/17/2025 Group One Trading LLC104,411$1.15M0.0%+2.8%0.197% 2/17/2025 Graham Capital Management L.P.18,634$206K0.0%+8.5%0.035% 2/17/2025 Granahan Investment Management LLC567,689$6.26M0.3%-12.0%1.072% 2/17/2025 D. E. Shaw & Co. Inc.28,043$309K0.0%-83.6%0.053% 2/17/2025 Deutsche Bank AG350,614$3.87M0.0%-24.2%0.662% 2/17/2025 DAFNA Capital Management LLC171,097$1.89M0.5%-17.5%0.323% 2/17/2025 Baker BROS. Advisors LP4,633,838$51.11M0.5%+6.1%8.748% 2/17/2025 Bank of America Corp DE9,091$100K0.0%-92.7%0.017% 2/17/2025 BNP Paribas Financial Markets4,422$49K0.0%-94.2%0.008% 2/17/2025 Ameriprise Financial Inc.10,527$116K0.0%-26.5%0.020% 2/14/2025 Jane Street Group LLC11,977$132K0.0%-96.4%0.023% 2/14/2025 Freestone Grove Partners LP18,049$199K0.0%N/A0.034% 2/14/2025 Schonfeld Strategic Advisors LLC291,795$3.22M0.0%N/A0.551% 2/14/2025 Northern Trust Corp350,788$3.87M0.0%+3.4%0.662% 2/14/2025 Tudor Investment Corp ET AL18,258$201K0.0%N/A0.034% 2/14/2025 Gilder Gagnon Howe & Co. LLC92,546$1.02M0.0%+2.0%0.175% 2/14/2025 Price T Rowe Associates Inc. MD37,455$414K0.0%+6.3%0.071% 2/14/2025 Tower Research Capital LLC TRC11,930$132K0.0%+70.1%0.023% 2/14/2025 Dimensional Fund Advisors LP538,900$5.94M0.0%+103.4%1.017% 2/13/2025 CANADA LIFE ASSURANCE Co9,716$107K0.0%-14.4%0.018% 2/13/2025 Marshall Wace LLP951,432$10.49M0.0%-43.1%1.796% 2/13/2025 Renaissance Technologies LLC129,043$1.42M0.0%N/A0.244% 2/13/2025 Legal & General Group Plc35,347$390K0.0%-5.7%0.067% 2/13/2025 Invesco Ltd.12,065$133K0.0%N/A0.023% 2/13/2025 Wells Fargo & Company MN16,786$185K0.0%+51.2%0.032% 2/12/2025 Trexquant Investment LP103,031$1.14M0.0%-36.3%0.195% 2/12/2025 Geode Capital Management LLC877,095$9.68M0.0%+0.7%1.656% 2/12/2025 Wellington Management Group LLP134,812$1.49M0.0%-1.6%0.255% 2/12/2025 Norges Bank314,800$3.47M0.0%N/A0.594% 2/12/2025 JPMorgan Chase & Co.19,964$220K0.0%+29.2%0.038% 2/11/2025 EntryPoint Capital LLC31,968$353K0.1%N/A0.060% 2/11/2025 Corebridge Financial Inc.17,861$197K0.0%-6.1%0.034% 2/11/2025 Vanguard Group Inc.2,731,198$30.13M0.0%-1.0%5.156% 2/11/2025 KLP Kapitalforvaltning AS5,700$63K0.0%N/A0.011% 2/11/2025 Teacher Retirement System of Texas10,219$113K0.0%N/A0.019% 2/10/2025 Swiss National Bank67,300$742K0.0%+20.4%0.127% 2/6/2025 Charles Schwab Investment Management Inc.342,129$3.77M0.0%+8.2%0.646% 2/5/2025 Skorpios Trust6,906,181$76.18M99.8%-22.5%13.038% 2/4/2025 Los Angeles Capital Management LLC43,438$479K0.0%-57.8%0.082% 2/4/2025 Bank of New York Mellon Corp93,195$1.03M0.0%+1.4%0.176% 1/30/2025 Rhumbline Advisers49,374$545K0.0%+6.0%0.093% Volatility Is Rising—But These 2 AI Stocks Could Thrive (Ad)2025 is off to a turbulent start—markets are swinging wildly, inflation pressures remain high, and recession fears are creeping back into headlines. But even in uncertain times, innovation doesn’t slow down. In fact, artificial intelligence (AI) is accelerating faster than ever—creating new profit opportunities while the broader market struggles. Our latest research reveals two AI stocks trading under $15 that could thrive even as volatility grows. These under-the-radar companies are positioned to ride the next wave of AI-driven demand—and they’re still flying below most investors’ radar.👉[Click here to access your FREE AI stocks report now.]1/24/2025 China Universal Asset Management Co. Ltd.11,231$124K0.0%N/A0.021% 1/17/2025 SG Americas Securities LLC10,768$119K0.0%-27.8%0.020% 1/14/2025 Assenagon Asset Management S.A.1,350,925$14.90M0.0%+2.9%2.551% 12/13/2024 Exome Asset Management LLC176,600$2.17M1.5%N/A0.333% 11/27/2024 Franklin Resources Inc.22,314$285K0.0%-98.2%0.042% 11/19/2024 Barclays PLC79,740$980K0.0%+145.3%0.151% 11/16/2024 Geode Capital Management LLC870,831$10.71M0.0%+9.7%1.644% 11/15/2024 Barclays PLC79,740$980K0.0%+145.3%0.151% 11/15/2024 Jane Street Group LLC330,442$4.06M0.0%+338.2%0.624% 11/15/2024 Wellington Management Group LLP136,975$1.68M0.0%-4.6%0.259% (Data available from 1/1/2016 forward) STOK Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of STOK shares? During the previous two years, 114 institutional investors and hedge funds held shares of Stoke Therapeutics. The most heavily invested institutionals were Skorpios Trust ($76.18M), Lynx1 Capital Management LP ($70.05M), RTW Investments LP ($56.51M), Baker BROS. Advisors LP ($51.11M), Cowen AND Company LLC ($39.56M), Toronto Dominion Bank ($35.00M), and Redmile Group LLC ($29.83M).Learn more on STOK's institutional investors. Which institutional investors have been buying Stoke Therapeutics stock? Of the 92 institutional investors that purchased Stoke Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Toronto Dominion Bank ($6.35M), Lynx1 Capital Management LP ($3.94M), Redmile Group LLC ($2.45M), Baker BROS. Advisors LP ($1.60M), Assenagon Asset Management S.A. ($1.51M), Healthcare of Ontario Pension Plan Trust Fund ($1.15M), and Logos Global Management LP ($1.05M). How much institutional buying is happening at Stoke Therapeutics? Institutional investors have bought a total of 27,708,051 shares in the last 24 months. This purchase volume represents approximately $307.73M in transactions. Which Stoke Therapeutics major shareholders have been selling company stock? Of the 47 institutional investors that sold Stoke Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Skorpios Trust ($3.94M), Franklin Resources Inc. ($1.19M), Marshall Wace LLP ($719.30K), Assenagon Asset Management S.A. ($547.05K), Deutsche Bank AG ($436.91K), Jane Street Group LLC ($318.47K), and Redmile Group LLC ($317.57K). How much institutional selling is happening at Stoke Therapeutics? Institutional investors have sold a total of 9,406,007 shares in the last 24 months. This volume of shares sold represents approximately $101.51M in transactions. Related Companies AAPG Major Shareholders KYMR Major Shareholders BHVN Major Shareholders IBRX Major Shareholders HRMY Major Shareholders TWST Major Shareholders BLTE Major Shareholders KNSA Major Shareholders ARWR Major Shareholders CGON Major Shareholders This page (NASDAQ:STOK) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stoke Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stoke Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.